XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income (Loss) per Share (Tables)
9 Months Ended
Sep. 30, 2023
Net Income (Loss) per Share [Abstract]  
Schedule of Basic and Diluted Loss Per Share The following table sets forth the computation of basic and diluted income (loss) per share (in thousands, except share and per share amounts):
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
Numerator:                
Net income (loss)  $1,563   $(1,339)  $(25,027)  $(4,446)
Less: Cumulative undeclared preferred dividends and undistributed earnings allocated to participating securities, basic   (230)   
-
    
-
    
-
 
Net income (loss) attributable to common stockholders, basic  $1,360   $(1,339)  $(25,027)  $(4,446)
                     
Net income (loss)  $1,563   $(1,339)  $(25,027)  $(4,446)
Less: Undistributed earnings allocated to participating securities, diluted   (159)   
-
    
-
    
-
 
Net income (loss) attributable to common stockholders, diluted  $1,404   $(1,339)  $(25,027)  $(4,446)
                     
Denominator:                    
Weighted average common stock outstanding, basic   10,214,183    10,123,187    10,153,564    10,123,187 
Net income (loss) per share attributable to common stockholders, basic  $0.13   $(0.13)  $(2.46)  $(0.44)
Weighted average common stock outstanding, diluted   11,215,068    10,123,187    10,153,564    10,123,187 
Net income (loss) per share attributable to common stockholders, diluted  $0.13   $(0.13)  $(2.46)  $(0.44)

 

Schedule of Potentially Dilutive Securities Have Been Excluded From the Computation of Diluted Net The Company excluded the following potential shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to stockholders for the periods indicated because including them would have had an anti-dilutive effect:
   Nine Months Ended
September 30,
 
   2023   2022 
Stock options   
-
    263,000 
Series A Preferred Stock (as converted to common stock)   3,913,043    
-
 
Warrants to purchase common stock   14,166,666    
-
 
Contingent Sponsor Shares   1,000,000    
-
 
    19,079,709    263,000